Connexin43 Mimetic Peptide Improves Retinal Function and Reduces Inflammation in a Light-Damaged Albino Rat Model
Open Access
- 1 August 2016
- journal article
- retina
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 57 (10) , 3961-3973
Abstract
Purpose: Drugs that regulate connexin43 (Cx43) gap junction channels can reduce the spread of injury and improve functional outcomes after nervous system trauma. In the eye, Cx43 expression increases in the choroid following light damage. The aim of this study was to investigate whether Cx43 hemichannel block could preserve retinal function postinjury. Methods: Light damage was induced by exposure of adult albino Sprague-Dawley rats to 2700 Lux light for 24 hours. Intravitreal injections of a Cx43 mimetic peptide hemichannel blocker, Peptide5, or sham were administered 2 hours after the onset and at the end of the light damage period. Retinal function was assessed by electroretinogram and inflammatory responses in the choroid and retina were assessed using immunohistochemistry (ionized calcium binding adaptor molecule 1 [Iba-1], leukocyte common antigen [CD45], glial fibrillary acidic protein [GFAP]). Results: Light-damaged rat eyes had (1) reduced neuronal responses in both the rod and cone pathways and (2) marked inflammatory responses in the choroid and retina. Peptide5 significantly preserved function of photoreceptoral and postphotoreceptoral neurons in these animals. This was evident 24 hours after injury and 2 weeks later, as shown by improved mixed a-wave and mixed b-wave amplitudes, isolated rod PII and PIII amplitudes, and cone PII responses when compared with sham-treated controls. Retinal thinning and inflammation were also significantly reduced in Peptide5-treated eyes when compared with sham-treated controls. Conclusions: Blocking Cx43 hemichannels after light damage can significantly improve functional outcomes of neurons in both the rod and cone photo-transduction pathways in the light-damaged animal model, likely by reducing choroid inflammation and suppressing the glial-mediated inflammatory response. These data may have relevance for the treatment of conditions such as diabetic retinopathy and age-related macular degeneration.Keywords
This publication has 57 references indexed in Scilit:
- The Use of Connexin-Based Therapeutic Approaches to Target Inflammatory Diseases2013
- The Role of Gap Junction Channels During Physiologic and Pathologic Conditions of the Human Central Nervous SystemJournal of Neuroimmune Pharmacology, 2012
- Connexin hemichannel blockade improves outcomes in a model of fetal ischemiaAnnals of Neurology, 2012
- Characterization of retinal function and glial cell response in a mouse model of oxygen‐induced retinopathyJournal of Comparative Neurology, 2010
- Limited intravascular coupling in the rodent brainstem and retina supports a role for glia in regional blood flowJournal of Comparative Neurology, 2008
- Alterations in photoreceptor‐bipolar cell signaling following ischemia/reperfusion in the rat retinaJournal of Comparative Neurology, 2007
- Turnover of resident retinal microglia in the normal adult mouseGlia, 2007
- Connexin immunoreactivity in glial cells of the rat retinaJournal of Comparative Neurology, 2002
- Cell Death in Retinitis Pigmentosa: Gap Junctions and the ‘Bystander’ EffectExperimental Eye Research, 2002
- Visualization and functional blocking of gap junction hemichannels (connexons) with antibodies against external loop domains in astrocytesGlia, 1998